EUPHRASIA OFFICINALIS (HOMEOLAB USA INC.)
Welcome to the PulseAid listing for the EUPHRASIA OFFICINALIS drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | HOMEOLAB USA INC. |
| NON-PROPRIETARY NAME: | EUPHRASIA OFFICINALIS |
| SUBSTANCE NAME: | EUPHRASIA STRICTA |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2013-11-18 |
| END MARKETING DATE: | 0000-00-00 |
EUPHRASIA OFFICINALIS HUMAN OTC DRUG Details:
| Item Description | EUPHRASIA OFFICINALIS from HOMEOLAB USA INC. |
| LABELER NAME: | HOMEOLAB USA INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1([hp_X]/1) |
| START MARKETING DATE: | 2013-11-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60512-1018_acb70833-8e89-4948-b3e2-9612c061435d |
| PRODUCT NDC: | 60512-1018 |
| APPLICATION NUMBER: | |
Other EUPHRASIA STRICTA Pharmaceutical Manufacturers / Labelers:
